Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016 | 2227 | 2016 |
Whole genomes redefine the mutational landscape of pancreatic cancer N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ... Nature 518 (7540), 495-501, 2015 | 2025 | 2015 |
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ... Nature 491 (7424), 399-405, 2012 | 1861 | 2012 |
Integrated genomic characterization of pancreatic ductal adenocarcinoma BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ... Cancer cell 32 (2), 185-203. e13, 2017 | 1002 | 2017 |
Pan-cancer analysis of whole genomes I The, TPCA of Whole, Genomes Consortium Nature 578 (7793), 82, 2020 | 824 | 2020 |
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature 551 (7681), 512-516, 2017 | 630 | 2017 |
Whole-genome landscape of pancreatic neuroendocrine tumours A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ... Nature 543 (7643), 65-71, 2017 | 568 | 2017 |
CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma CW Steele, SA Karim, JDG Leach, P Bailey, R Upstill-Goddard, L Rishi, ... Cancer cell 29 (6), 832-845, 2016 | 536 | 2016 |
Interrogating open issues in cancer precision medicine with patient-derived xenografts AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ... Nature Reviews Cancer 17 (4), 254-268, 2017 | 462 | 2017 |
Molecular subtypes of pancreatic cancer EA Collisson, P Bailey, DK Chang, AV Biankin Nature reviews Gastroenterology & hepatology 16 (4), 207-220, 2019 | 369 | 2019 |
Qualité Des Marges D'Exérèse Et évolution Du Cancer Du Pancréas Opéré N Merrett J clin oncol 27, 2855-2862, 2009 | 327 | 2009 |
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ... Nature 486 (7402), 266-270, 2012 | 308 | 2012 |
The prognostic and predictive value of serum CA19. 9 in pancreatic cancer JL Humphris, DK Chang, AL Johns, CJ Scarlett, M Pajic, MD Jones, ... Annals of oncology 23 (7), 1713-1722, 2012 | 261 | 2012 |
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma KM Mann, JM Ward, CCK Yew, A Kovochich, DW Dawson, MA Black, ... Proceedings of the National Academy of Sciences 109 (16), 5934-5941, 2012 | 212 | 2012 |
Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial LA Chantrill, AM Nagrial, C Watson, AL Johns, M Martyn-Smith, ... Clinical cancer research 21 (9), 2029-2037, 2015 | 203 | 2015 |
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy BW Miller, JP Morton, M Pinese, G Saturno, NB Jamieson, E McGhee, ... EMBO molecular medicine 7 (8), 1063-1076, 2015 | 202 | 2015 |
Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling K Nones, N Waddell, S Song, AM Patch, D Miller, A Johns, J Wu, ... International journal of cancer 135 (5), 1110-1118, 2014 | 191 | 2014 |
Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer CJ Halbrook, C Pontious, I Kovalenko, L Lapienyte, S Dreyer, HJ Lee, ... Cell metabolism 29 (6), 1390-1399. e6, 2019 | 189 | 2019 |
The histone deacetylase SIRT2 stabilizes Myc oncoproteins PY Liu, N Xu, A Malyukova, CJ Scarlett, YT Sun, XD Zhang, D Ling, SP Su, ... Cell Death & Differentiation 20 (3), 503-514, 2013 | 179 | 2013 |
Hypermutation in pancreatic cancer JL Humphris, AM Patch, K Nones, PJ Bailey, AL Johns, S McKay, ... Gastroenterology 152 (1), 68-74. e2, 2017 | 165 | 2017 |